-
1Academic Journal
المصدر: Journal of Clinical Medicine, Vol 13, Iss 9, p 2675 (2024)
مصطلحات موضوعية: warfarin, atrial fibrillation, warfarin dose, Medicine
Relation: https://www.mdpi.com/2077-0383/13/9/2675; https://doaj.org/toc/2077-0383; https://doaj.org/article/fd01a1189aa04ef29e7a5b4e8dca255e
-
2Academic Journal
المصدر: مجله انفورماتیک سلامت و زیست پزشکی, Vol 9, Iss 4, Pp 209-229 (2023)
مصطلحات موضوعية: pharmacogenomics, initial warfarin dose estimation, feature selection, least squares support vector regression, Computer applications to medicine. Medical informatics, R858-859.7, Medical technology, R855-855.5
وصف الملف: electronic resource
-
3Academic Journal
المؤلفون: Laith N. AL-Eitan, Ayah Y. Almasri, Adan H. Alnaamneh, Ahmad Mihyar
مصطلحات موضوعية: Cell Biology, Genetics, Pharmacology, Biotechnology, Cancer, Science Policy, Infectious Diseases, Biological Sciences not elsewhere classified, Mathematical Sciences not elsewhere classified, genes may help, 213 healthy controls, lpa gene cluster, needed warfarin dose, adverse drug effects, cardiovascular disease susceptibility, lpa gene polymorphisms, moderate warfarin sensitivity, cardiovascular disease, lpa rs10455872, lpa <, healthy individuals, mef2a gene, cardiovascular patients, warfarin sensitivity, warfarin metabolism, warfarin medication, warfarin efficiency,
%22">xlink ">, study aims, significant differences -
4Academic Journal
المصدر: Journal of Kerman University of Medical Sciences, Vol 28, Iss 2, Pp 139-149 (2021)
مصطلحات موضوعية: warfarin dose, warfarin pharmacogenetics, warfarin pharmacogenomics, cyp2c9, vkorc1, Immunologic diseases. Allergy, RC581-607, Diseases of the circulatory (Cardiovascular) system, RC666-701
وصف الملف: electronic resource
-
5Academic Journal
المؤلفون: Yanyun Tao, Yuzhen Zhang, Bin Jiang
المصدر: BMC Medical Genomics, Vol 13, Iss S10, Pp 1-13 (2020)
مصطلحات موضوعية: Warfarin dose prediction, Data imbalance, Oversampling, Density clustering, Predictive models, Internal medicine, RC31-1245, Genetics, QH426-470
وصف الملف: electronic resource
-
6Academic Journal
المؤلفون: Xuerong Wen (491631), Shuang Wang (46453), Tracey H. Taveira (11436950), Fatemeh Akhlaghi (4503211)
مصطلحات موضوعية: Biochemistry, Science Policy, Hematology, Biological Sciences not elsewhere classified, Chemical Sciences not elsewhere classified, least 2 months, generalized linear models, 52 8211, average daily dose, retrospective study utilizing,
+warfarin%22">xlink "> warfarin, ttr (& gt, required warfarin dose, nash ) p, patients without obesity, patients without diabetes, warfarin dose, study aims, without nafld, warfarin dispensing, patients diagnosed, patients accounting, nash patients, widely used, ttr ), treat thromboembolism, therapeutic range, shorter ttr, relative differences, propensity score -
7
المؤلفون: Eriksson, Niclas, Wallentin, Lars, Berglund, Lars, Axelsson, Tomas, Connolly, Stuart, Eikelboom, John, Ezekowitz, Michael, Oldgren, Jonas, Pare, Guillaume, Reilly, Paul, Siegbahn, Agneta, Syvänen, Ann-Christine, Wadelius, Claes, Yusuf, Salim, Wadelius, Mia
المصدر: Pharmacogenomics (London). 17(13):1425-1439
مصطلحات موضوعية: CYP2C9, CYP4F2, genome-wide association study, prediction models, time in therapeutic range, VKORC1, warfarin, warfarin dose
وصف الملف: electronic
-
8Academic Journal
المؤلفون: Assaf Gottlieb, Roxana Daneshjou, Marianne DeGorter, Stephane Bourgeois, Peter J. Svensson, Mia Wadelius, Panos Deloukas, Stephen B. Montgomery, Russ B. Altman
المصدر: Genome Medicine, Vol 9, Iss 1, Pp 1-9 (2017)
مصطلحات موضوعية: Pharmacogenomics, Warfarin dose, International Warfarin Pharmacogenetics Consortium, African Americans, Medicine, Genetics, QH426-470
وصف الملف: electronic resource
-
9Academic Journal
المصدر: Journal of Personalized Medicine; Volume 10; Issue 3; Pages: 117
مصطلحات موضوعية: warfarin, warfarin dose, cardiovascular disease, pharmacogenetics, INR, MTHFD1L, SH2B3
وصف الملف: application/pdf
Relation: Mechanisms of Diseases; https://dx.doi.org/10.3390/jpm10030117
الاتاحة: https://doi.org/10.3390/jpm10030117
-
10Academic Journal
المؤلفون: E. L. Artanova, E. V. Saleeva, I. M. Sokolov, Y. G. Shvarts
المصدر: Рациональная фармакотерапия в кардиологии, Vol 7, Iss 4, Pp 442-446 (2016)
مصطلحات موضوعية: warfarin dose, atrial fibrillation, ischemic heart disease, international normalized ratio, Therapeutics. Pharmacology, RM1-950, Diseases of the circulatory (Cardiovascular) system, RC666-701
وصف الملف: electronic resource
-
11
المؤلفون: Low Seow Huey, Ang Kee Hooi, Valliyamai A, Ishmah Musfirah Nazari, P Suppiah, Oon Xin Ying, Ng Yinwen
المصدر: Malaysian Journal of Pharmaceutical Sciences. 19:47-60
مصطلحات موضوعية: medicine.medical_specialty, business.industry, Internal medicine, Warfarin dose, medicine, Cardiology, International normalised ratio, Time in therapeutic range, Atrial fibrillation, cardiovascular diseases, medicine.disease, business
-
12
المؤلفون: Heejin Hur, Annesti F. Elmasri, James C. Lee, Jin Han
المصدر: Expert Review of Precision Medicine and Drug Development. 6:375-379
مصطلحات موضوعية: Pharmacology, medicine.medical_specialty, education.field_of_study, business.industry, Warfarin dose, Population, Warfarin, Internal medicine, Drug Discovery, Genotype, Genetics, medicine, Molecular Medicine, heterocyclic compounds, cardiovascular diseases, Dosing, VKORC1, business, education, CYP2C9, Pharmacogenetics, medicine.drug
-
13
المصدر: Journal of Cardiovascular Pharmacology. 78:474-479
مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Poison Control Centers, Antidotes, Patient characteristics, Hemorrhage, Time-to-Treatment, Predictive Value of Tests, Interquartile range, Internal medicine, medicine, Humans, heterocyclic compounds, In patient, International Normalized Ratio, cardiovascular diseases, Blood Coagulation, Aged, Retrospective Studies, Pharmacology, Maryland, business.industry, Warfarin dose, Warfarin, Anticoagulants, Retrospective cohort study, Vitamin K 1, Middle Aged, Antifibrinolytic Agents, Time to peak, Female, Drug Overdose, Cardiology and Cardiovascular Medicine, business, Warfarin overdose, medicine.drug
-
14
المؤلفون: Laith N. AL-Eitan, Ayah Y. Almasri, Adan H. Alnaamneh, Ahmad Mihyar
مصطلحات موضوعية: Cell Biology, Genetics, Pharmacology, Biotechnology, Cancer, Science Policy, Infectious Diseases, Biological Sciences not elsewhere classified, Mathematical Sciences not elsewhere classified, genes may help, 213 healthy controls, lpa gene cluster, needed warfarin dose, adverse drug effects, cardiovascular disease susceptibility, lpa gene polymorphisms, moderate warfarin sensitivity, cardiovascular disease, lpa rs10455872, lpa <, healthy individuals, mef2a gene, cardiovascular patients, warfarin sensitivity, warfarin metabolism, warfarin medication, warfarin efficiency,
%22">xlink ">, study aims, significant differences -
15
المؤلفون: Laith N. AL-Eitan, Ayah Y. Almasri, Adan H. Alnaamneh, Ahmad Mihyar
مصطلحات موضوعية: Cell Biology, Genetics, Pharmacology, Biotechnology, Cancer, Science Policy, Infectious Diseases, Biological Sciences not elsewhere classified, Mathematical Sciences not elsewhere classified, genes may help, 213 healthy controls, lpa gene cluster, needed warfarin dose, adverse drug effects, cardiovascular disease susceptibility, lpa gene polymorphisms, moderate warfarin sensitivity, cardiovascular disease, lpa rs10455872, lpa <, healthy individuals, mef2a gene, cardiovascular patients, warfarin sensitivity, warfarin metabolism, warfarin medication, warfarin efficiency,
%22">xlink ">, study aims, significant differences -
16
المؤلفون: Laith N. AL-Eitan, Ayah Y. Almasri, Adan H. Alnaamneh, Ahmad Mihyar
مصطلحات موضوعية: Cell Biology, Genetics, Pharmacology, Biotechnology, Cancer, Science Policy, Infectious Diseases, Biological Sciences not elsewhere classified, Mathematical Sciences not elsewhere classified, genes may help, 213 healthy controls, lpa gene cluster, needed warfarin dose, adverse drug effects, cardiovascular disease susceptibility, lpa gene polymorphisms, moderate warfarin sensitivity, cardiovascular disease, lpa rs10455872, lpa <, healthy individuals, mef2a gene, cardiovascular patients, warfarin sensitivity, warfarin metabolism, warfarin medication, warfarin efficiency,
%22">xlink ">, study aims, significant differences -
17
المؤلفون: Laith N. AL-Eitan, Ayah Y. Almasri, Adan H. Alnaamneh, Ahmad Mihyar
مصطلحات موضوعية: Cell Biology, Genetics, Pharmacology, Biotechnology, Cancer, Science Policy, Infectious Diseases, Biological Sciences not elsewhere classified, Mathematical Sciences not elsewhere classified, genes may help, 213 healthy controls, lpa gene cluster, needed warfarin dose, adverse drug effects, cardiovascular disease susceptibility, lpa gene polymorphisms, moderate warfarin sensitivity, cardiovascular disease, lpa rs10455872, lpa <, healthy individuals, mef2a gene, cardiovascular patients, warfarin sensitivity, warfarin metabolism, warfarin medication, warfarin efficiency,
%22">xlink ">, study aims, significant differences -
18
المؤلفون: Laith N. AL-Eitan, Ayah Y. Almasri, Adan H. Alnaamneh, Ahmad Mihyar
مصطلحات موضوعية: Cell Biology, Genetics, Pharmacology, Biotechnology, Cancer, Science Policy, Infectious Diseases, Biological Sciences not elsewhere classified, Mathematical Sciences not elsewhere classified, genes may help, 213 healthy controls, lpa gene cluster, needed warfarin dose, adverse drug effects, cardiovascular disease susceptibility, lpa gene polymorphisms, moderate warfarin sensitivity, cardiovascular disease, lpa rs10455872, lpa <, healthy individuals, mef2a gene, cardiovascular patients, warfarin sensitivity, warfarin metabolism, warfarin medication, warfarin efficiency,
%22">xlink ">, study aims, significant differences -
19
المؤلفون: Laith N. AL-Eitan, Ayah Y. Almasri, Adan H. Alnaamneh, Ahmad Mihyar
مصطلحات موضوعية: Cell Biology, Genetics, Pharmacology, Biotechnology, Cancer, Science Policy, Infectious Diseases, Biological Sciences not elsewhere classified, Mathematical Sciences not elsewhere classified, genes may help, 213 healthy controls, lpa gene cluster, needed warfarin dose, adverse drug effects, cardiovascular disease susceptibility, lpa gene polymorphisms, moderate warfarin sensitivity, cardiovascular disease, lpa rs10455872, lpa <, healthy individuals, mef2a gene, cardiovascular patients, warfarin sensitivity, warfarin metabolism, warfarin medication, warfarin efficiency,
%22">xlink ">, study aims, significant differences -
20
المؤلفون: Laith N. AL-Eitan, Ayah Y. Almasri, Adan H. Alnaamneh, Ahmad Mihyar
مصطلحات موضوعية: Cell Biology, Genetics, Pharmacology, Biotechnology, Cancer, Science Policy, Infectious Diseases, Biological Sciences not elsewhere classified, Mathematical Sciences not elsewhere classified, genes may help, 213 healthy controls, lpa gene cluster, needed warfarin dose, adverse drug effects, cardiovascular disease susceptibility, lpa gene polymorphisms, moderate warfarin sensitivity, cardiovascular disease, lpa rs10455872, lpa <, healthy individuals, mef2a gene, cardiovascular patients, warfarin sensitivity, warfarin metabolism, warfarin medication, warfarin efficiency,
%22">xlink ">, study aims, significant differences